^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    F0002-ADC

    i
    Other names: F-0002, F0002-ADC, F0002, anti-CD30-MCC-DM1, Anti-CD30/DM1 ADC F0002, Anti-CD30/DM1 Antibody-drug Conjugate F0002, F 0002
    Company:
    Shanghai Fudan-Zhangjiang
    Drug class:
    Microtubule inhibitor, CD30-targeted antibody-drug conjugate
    Related drugs:
    6ms
    A Study of F0002-ADC in Chinese Patients With Refractory or Recurrent CD30+ Hematologic Malignancies. (clinicaltrials.gov)
    P1, N=45, Completed, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Recruiting --> Completed | N=23 --> 45
    Trial completion • Enrollment change
    |
    TNFRSF8 (TNF Receptor Superfamily Member 8)
    |
    F0002-ADC